Official ESCRS | European Society of Cataract & Refractive Surgeons
Barcelona 2015 Programme Registration Glaucoma Day 2015 Exhibition Virtual Exhibition Satellite Meetings Hotel Booking Star Alliance

Take a look inside the London 2014 Congress


Then register to join us
in Barcelona!

Endophthalmitis following phacoemulsification in 22,000 procedures: clinics, visual outcome and microbiological spectrum

Search Abstracts by author or title
(results will display both Free Papers & Poster)

Session Details

Session Title: Endophthalmitis/Ocular Infections

Session Date/Time: Wednesday 09/09/2015 | 08:00-09:30

Paper Time: 09:00

Venue: Room 8

First Author: : C.Garcia- Saenz SPAIN

Co Author(s): :    Y. Andres-Alba   A. Arias-Puente   G. Rodriguez-Caravaca              

Abstract Details


To describe the primary clinical and epidemiological data and outcome of endophthalmitis following cataract surgery


Hospital Universitario Fundación Alcorcón ,Madrid, Spain


Prospective descriptive analysis of the primary clinical and surgical data on endophthalmitis following cataract surgery recorded in a 16-year period (1999–2014) in a public hospital in Spain


There were 44 cases of endophthalmitis in 22127 cataract surgeries (0.21%). In 39 cases the patients did not receive cefuroxime. The mean age of infected patients was 76. The onset of 75% of the cases occurred between the first and fifth day after surgery. Risk factors included: 25% diabetes, 9% dacryocystitis and 43% ASA III–IV. There was capsular rupture in 18%. Injectable lenses were implanted in 56%. Cultures were positive in 29, with a Staphylococcus origin in more than 70%. During the cefuroxime period, 2 cultures were isolated: 1 Enterococcus faecalis and 1 Staphylococcus aureus. The final visual acuity was greater than 0.5 in 48%, while in 27% it was lesser than 0.1 and 3 patients experienced ptisis bulbi.


Almost half of endophthalmitis cases had a systematically increased risk. Final mean visual acuity was better than preoperative visual acuity. The use of cefuroxime was an important protective factor, and clinical outcome was better than the rest of endophthalmitis cases.

Financial Interest:


Back to previous